SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-285170
Filing Date
2023-11-29
Accepted
2023-11-29 16:02:58
Documents
5
Period of Report
2023-11-29

Document Format Files

Seq Description Document Type Size
1 6-K d614273d6k.htm 6-K 9027
2 EX-99.1 d614273dex991.htm EX-99.1 58897
3 GRAPHIC g614273g1129100033338.jpg GRAPHIC 7252
4 GRAPHIC g614273g14p01.jpg GRAPHIC 371122
5 GRAPHIC g614273g15p01.jpg GRAPHIC 263738
  Complete submission text file 0001193125-23-285170.txt   953889
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 231452142
SIC: 2834 Pharmaceutical Preparations